Centre Hospitalier D Auxerre
- Address
- lock Available on a paid plan
Oncology and Neoplasms
At Centre Hospitalier D Auxerre, the Oncology research portfolio focuses on cancer care, with studies centered on improving treatment choices for patients with advanced disease. The main aim is to better understand which therapies may offer the greatest benefit in metastatic breast cancer and related solid tumors.
- Research in metastatic breast cancer with a focus on HR+, HER2- disease
- Evaluation of treatment effectiveness to help guide the next therapy after standard care
- Use of blood-based tumor DNA detection to support more personalized cancer treatment
This work reflects a strong interest in precision oncology, aiming to match patients with therapies that may better control their cancer and delay progression.
Digestive System Diseases and Oral Physiological Phenomena
The site is also active in Digestive System Diseases, particularly cancers affecting the digestive tract. These trials explore new ways to improve outcomes for patients with small bowel adenocarcinoma, a rare and challenging malignancy.
- Studies in small bowel adenocarcinoma and related digestive system cancers
- Comparison of treatment approaches for locally advanced or metastatic disease
- Assessment of whether new chemotherapy strategies can improve survival without progression
Overall, the research at this hospital combines cancer treatment innovation with a focus on better disease control in both breast and digestive system oncology.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 7 therapeutic areas and 15 of 55 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 55 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 8 by active trials.
lock +7 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +3 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier D Auxerre
lock Showing 1 of 30 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Double-Blind Randomized Controlled Trial of Clostridium Botulinum Neurotoxin Type A Injection in Preoperative Management of Large Incisional Hernia | Assistance Publique Hopitaux De Paris | Phase III | Recruiting | Jan 2025 | — |
IMP list
lock Showing 1 of 55 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluorouracil | 10 | Unknown | 2014-12-23 | 2026-05-07 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.